Phathom Pharmaceuticals (PHAT) Gross Margin (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted Gross Margin of 79.68% for Q2 2026, down 7.57 percentage points from 87.25% a year earlier but up 0.25 percentage points from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Gross Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Phathom Pharmaceuticals was 82.92%, down 3.98 percentage points year-over-year; for FY2025, it was 87.09%, up 1.52 percentage points from FY2024.
- In prior years, Phathom Pharmaceuticals' Gross Margin was 85.57% in FY2024 (+10.06 pp) and 75.51% in FY2023.
- Quarterly Gross Margin has run from a low of 75.51% in Q4 2023 to a high of 87.50% in Q3 2025 over five years.
- On a year-over-year basis, Gross Margin has declined in each of the last three quarters, with an average year-over-year change of +1.90 percentage points over the last seven quarters.
- According to Business Quant data, Gross Margin for the three prior quarters was 79.42% (Q1 2026), 86.72% (Q4 2025) and 87.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Phathom Pharmaceuticals | 588.51 Mn | -51.44 Mn | 59.18 Mn | 79.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.68% |
| Mar 31, 2026 | 79.42% |
| Dec 31, 2025 | 86.72% |
| Sep 30, 2025 | 87.50% |
| Jun 30, 2025 | 87.25% |
| Mar 31, 2025 | 86.94% |
| Dec 31, 2024 | 87.14% |
| Sep 30, 2024 | 85.59% |
| Jun 30, 2024 | 81.21% |
| Mar 31, 2024 | 77.72% |
| Dec 31, 2023 | 75.51% |
API Access
Phathom Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();